NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
16.97
-0.03 (-0.15%)
May 20, 2025, 9:30 AM - Market open
NeuroPace Employees
NeuroPace had 184 employees as of December 31, 2024. The number of employees increased by 13 or 7.60% compared to the previous year.
Employees
184
Change (1Y)
13
Growth (1Y)
7.60%
Revenue / Employee
$458,185
Profits / Employee
-$134,810
Market Cap
556.72M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 184 | 13 | 7.60% |
| Dec 31, 2023 | 171 | 4 | 2.40% |
| Dec 31, 2022 | 167 | 1 | 0.60% |
| Dec 31, 2021 | 166 | 14 | 9.21% |
| Dec 31, 2020 | 152 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
NPCE News
- 6 days ago - NeuroPace, Inc. (NPCE) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - NeuroPace Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - NeuroPace Provides Update on Tariff Status - GlobeNewsWire
- 6 weeks ago - NeuroPace Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal Epilepsy at the 2025 AAN Annual Meeting - GlobeNewsWire
- 6 weeks ago - NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting - GlobeNewsWire
- 6 weeks ago - NeuroPace Announces Refocusing of Product Portfolio - GlobeNewsWire
- 7 weeks ago - NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 2 months ago - NeuroPace, Inc. (NPCE) Q4 2024 Earnings Call Transcript - Seeking Alpha